2007
DOI: 10.3109/s10165-007-0645-0
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2008
2008
2010
2010

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 0 publications
1
3
0
Order By: Relevance
“…However, the frequencies of the IL‐10 SNPs differ significantly from the Caucasian cohorts 10,22 . As reported previously, the SNPs at positions –824 and –597 in the promoter of the human IL‐10 gene were found to be in complete linkage disequilibrium and the genotype distribution was found to be identical for these two polymorphisms 19 …”
Section: Discussionsupporting
confidence: 52%
See 2 more Smart Citations
“…However, the frequencies of the IL‐10 SNPs differ significantly from the Caucasian cohorts 10,22 . As reported previously, the SNPs at positions –824 and –597 in the promoter of the human IL‐10 gene were found to be in complete linkage disequilibrium and the genotype distribution was found to be identical for these two polymorphisms 19 …”
Section: Discussionsupporting
confidence: 52%
“…However, we were unable to detect any significant correlations between the SNP haplotypes and SLE incidence when the data was analyzed individually. Other investigators have found no association with Chinese, 19 Dutch 29 and British 30 SLE patients. The GCC haplotype was correlated with anti‐Ro (SSA) autoantibodies in British Caucasians 31 while the ATA haplotype was reported to be associated with renal disease in Chinese SLE patients 26 but not in Dutch 29 or British SLE patients 30 .…”
Section: Discussionmentioning
confidence: 88%
See 1 more Smart Citation
“…Genomic DNA was extracted from peripheral blood leukocytes using a genomic isolation DNA commercial kit as recommended by the manufacturer (QIAGEN, Germany). The extracted DNA was amplified by PCR using published forward and reverse primers (Padyukov et al 2004; Hee et al 2007) (LNTRON Biotechnology, Korea). PCR was performed using commercially available PCR premix according to the manufacturer's recommendation protocol (DMTRON Biotechnology, Korea) and a PTC‐100 Pltier thermal cycle (MJ Research).…”
Section: Methodsmentioning
confidence: 99%